Next Article in Journal
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study
Next Article in Special Issue
Synergistic Anti-Tumor Efficacy of Modified FOLFIRINOX and NK Cell Therapy in Pancreatic Ductal Adenocarcinoma
Previous Article in Journal
ERRα and HIF-1α Cooperate to Enhance Breast Cancer Aggressiveness and Chemoresistance Under Hypoxic Conditions
Previous Article in Special Issue
Immunotherapy for High-Grade Gliomas
 
 
Article

Article Versions Notes

Cancers 2025, 17(14), 2383; https://doi.org/10.3390/cancers17142383
Action Date Notes Link
article xml file uploaded 18 July 2025 08:52 CEST Original file -
article xml uploaded. 18 July 2025 08:52 CEST Update https://www.mdpi.com/2072-6694/17/14/2383/xml
article pdf uploaded. 18 July 2025 08:52 CEST Version of Record https://www.mdpi.com/2072-6694/17/14/2383/pdf
article supplementary file uploaded. 18 July 2025 08:52 CEST - https://www.mdpi.com/2072-6694/17/14/2383#supplementary
article html file updated 18 July 2025 08:56 CEST Original file https://www.mdpi.com/2072-6694/17/14/2383/html
Back to TopTop